Resource utilization and costs in the Candesartan in Heart failure : Assessment of Reduction in Mortality and morbidity (CHARM) programme
European heart journal, 2006-06, Vol.27 (12), p.1447-1458 [Peer Reviewed Journal]2006 INIST-CNRS ;ISSN: 0195-668X ;EISSN: 1522-9645 ;DOI: 10.1093/eurheartj/ehl016 ;PMID: 16754631
Full text available